| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.8 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |